Recent studies reported that CD163+ TAMs were associated with PD-L1 expression on tumor cells in several human cancers, including gastric adenocarcinoma, ovarian cancer, NSCLC, and so forth [36–39]. This evidence concerns the gene CD163 and gastric adenocarcinoma.